← Eichor
Condition: Liver Transplant Recipient Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Liver Transplant Recipient

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Leveraging Technology to Improve Medication Adherence in Youth With Kidney or Liver Transplant
NA · 1 location(s) · Johns Hopkins University · NCT05613010Impact of a TDM-guided ECPA Program for Optimizing Pharmacodynamic Target Attainment of Continuous Infusion Beta-lactam-
Phase N/A · 1 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06718517Proteogenomic Monitoring and Assessment of Liver Transplant Recipients
Phase N/A · 1 location(s) · Northwestern University · NCT01644903Influence of Donor and Recipient Genetic Polymorphisms on Graft Steatosis After Liver Transplant
Phase N/A · 1 location(s) · Institute of Liver and Biliary Sciences, India · NCT07685353Strategic Help With Immunoglobulin to Enhance Protect Against Late Disease (CMV)
Phase 4 · 2 location(s) · Camille N. Kotton, MD · NCT06958796Tacrolimus Associated Tremors in Liver Transplantation: Immediate-Release Versus Extended-Release Formulations
Phase 4 · 1 location(s) · University of British Columbia · NCT05089604Liver Transplant Recipients and 30-Second Lie-to-Sit Test
Phase N/A · 1 location(s) · Inonu University · NCT07365098HEalth Advocate for Liver Transplantation: Improving Transition of Care for Adolescent Liver Transplant Recipients
NA · 2 location(s) · University of California, San Francisco · NCT06386198Longitudinal Follow-up and Health-Related Outcomes in Liver Transplant Recipients and Living Donors
Phase N/A · 1 location(s) · Second Affiliated Hospital, School of Medicine, Zhejiang Uni · NCT07301853Quantiferon CMV to Identify Treatment Need for Asymptomatic CMV Infection After Solid Organ Transplant (QUANTIFOT)
NA · 1 location(s) · University Hospital, Grenoble · NCT06341543Serum Glycomics as Prognostic and Diagnostic Biomarkers of Disease Recurrence in Liver Transplant Recipients With Hepato
Phase N/A · 1 location(s) · University Hospital, Ghent · NCT05866783Effect of Preoperative Vitamin D Supplementation in Liver Transplant Recipients With Vitamin D Deficiency on Post Transp
NA · 1 location(s) · Institute of Liver and Biliary Sciences, India · NCT06736093Biodegradable Stents in Liver Transplant RecipIents for Treatment of Biliary Anastomotic Strictures
NA · 1 location(s) · Institute for Clinical and Experimental Medicine · NCT06716541A Survey on Growth Development in Children After Liver Transplantation
Phase N/A · 1 location(s) · RenJi Hospital · NCT07574398Single-center Prospective Study of Non-invasive Methods for the Diagnosis of Postoperative Complications in Liver Transp
Phase N/A · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT05793203Effect of Oral Semaglutide on Liver Fat and Body Composition in Liver Transplant Recipients With Diabetes Mellitus
NA · 1 location(s) · Medanta, The Medicity, India · NCT06060392"Duration of Preoperative Clear Fluids Fasting in Patients Undergoing Liver Transplant"
Phase N/A · 1 location(s) · Medical University of Warsaw · NCT07288281Prospective, Multicenter Clinical Study of Prolonged-release Tacrolimus in Stable Pediatric Liver Transplant Recipients
NA · 1 location(s) · RenJi Hospital · NCT06183892Feasibility and Acceptability of a New Tool Promoting a Healthy Lifestyle in Liver and Kidney Transplant Recipients
NA · 1 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT07305012Magnetic Resonance Cholangiopancreatography in Living Liver Donors and Its Relationship With Post Operative Recipient Bi
NA · 1 location(s) · Institute of Liver and Biliary Sciences, India · NCT07715500Perioperative Analgesia With Erector Spinae Plane Block in Liver Transplant Recipients
NA · 1 location(s) · Bogomolets National Medical University · NCT06857331Combined Light, ExVivo, and Antivirals for Recipients of Lungs From HBV Donors
Phase 4 · 1 location(s) · University Health Network, Toronto · NCT07189377
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.